Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Segmentation and Geographical Analysis 2021
Market by Therapeutics (Marketed Drugs, Pipeline Drugs), by Diagnostics (Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others) and by Region
(EMAILWIRE.COM, October 03, 2017 ) According to the report Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market, published by Market Data Forecast the Market was worth USD 0.69 billion in 2016 and estimated to be growing at a CAGR of 4.08%, to reach USD 0.84 billion by 2021. Alzheimer’s disease (AD) is the most regular cause of progressive dementia in the elderly populace. There has been an exponential increase in the frequency of Alzheimer’s disease cases globally, stressing the need to develop an effectual treatment to cure it.
These days, very few therapeutic options are present in the market and none of them offer a complete remedy for this condition. Hence, entry into the market would provide lucrative growth prospects to the industry players.
Browse market data tables and in-depth TOC of the Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Industry to 2021 @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-alzheimers-disease-therapeutics-and-diagnostics-market-2252/
The growth of the Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market is mainly driven by factors such as growing old age population, rising R&D investment, high frequency of Alzheimer’s and neurodegenerative diseases, and improved life expectancy of the general population. However, factors such as astronomical cost of treatment and lack of proper reimbursement policies are preventing the growth of the market in this region.
The Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics market is segmented based on Therapeutics and Diagnostics. The market for Alzheimer’s disease Therapeutics and Diagnostics, on the basis of Therapeutics is segmented into Marketed Drugs and Pipeline Drugs. Marketed Drugs are further segmented into NMDA Receptor Antagonists and Cholinesterase Inhibitors. Marketed Drugs lead the market on the basis of Therapeutics due to a large user base.
On the basis of Diagnostics, the Alzheimer’s disease Therapeutics and Diagnostics market is segmented into Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others. Under this segment, Computed tomography scan segment leads the Alzheimer’s disease Therapeutics and Diagnostics market. Absence of alternative imaging tool for brain and neurological diagnostics is one of the crucial reasons for its large share.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-alzheimers-disease-therapeutics-and-diagnostics-market-2252/request-sample
The market has been geographically segmented into Middle East and Africa. One of the major drivers of growth for the Alzheimer’s disease Therapeutics and Diagnostics market in this region is the growth of population aged above 65 years, which provide ample opportunities for the growth of drugs treating Alzheimer’s disease. In addition, the national governments in this region have stepped up efforts to increase access to healthcare for its citizens.
Leading companies have applied tactics such as mergers & acquisitions, collaborations, and joint ventures to gain a strong foothold in the market. The major companies dominating the Alzheimer’s Disease Therapeutics and Diagnostics market in this region are Abbvie Inc., Pfizer Inc., AC Immune SA, Eisai Co Ltd., Allergan PLC, Novartis AG, Amarantus Bioscience Holdings, H. Lundbeck A/S, Anavex LifeSciences, Avid Radiopharmaceuticals, Forest Laboratories Inc., Axon Neuroscience, Daiichi Sankyo Co, TauRx Therapeutics Ltd, Eli Lilly, F. Hoffmann La Roche AG, Johnson & Johnson, GE Healthcare, Janssen Pharmaceuticals etc.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-alzheimers-disease-therapeutics-and-diagnostics-market-2252/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
These days, very few therapeutic options are present in the market and none of them offer a complete remedy for this condition. Hence, entry into the market would provide lucrative growth prospects to the industry players.
Browse market data tables and in-depth TOC of the Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Industry to 2021 @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-alzheimers-disease-therapeutics-and-diagnostics-market-2252/
The growth of the Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market is mainly driven by factors such as growing old age population, rising R&D investment, high frequency of Alzheimer’s and neurodegenerative diseases, and improved life expectancy of the general population. However, factors such as astronomical cost of treatment and lack of proper reimbursement policies are preventing the growth of the market in this region.
The Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics market is segmented based on Therapeutics and Diagnostics. The market for Alzheimer’s disease Therapeutics and Diagnostics, on the basis of Therapeutics is segmented into Marketed Drugs and Pipeline Drugs. Marketed Drugs are further segmented into NMDA Receptor Antagonists and Cholinesterase Inhibitors. Marketed Drugs lead the market on the basis of Therapeutics due to a large user base.
On the basis of Diagnostics, the Alzheimer’s disease Therapeutics and Diagnostics market is segmented into Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others. Under this segment, Computed tomography scan segment leads the Alzheimer’s disease Therapeutics and Diagnostics market. Absence of alternative imaging tool for brain and neurological diagnostics is one of the crucial reasons for its large share.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-alzheimers-disease-therapeutics-and-diagnostics-market-2252/request-sample
The market has been geographically segmented into Middle East and Africa. One of the major drivers of growth for the Alzheimer’s disease Therapeutics and Diagnostics market in this region is the growth of population aged above 65 years, which provide ample opportunities for the growth of drugs treating Alzheimer’s disease. In addition, the national governments in this region have stepped up efforts to increase access to healthcare for its citizens.
Leading companies have applied tactics such as mergers & acquisitions, collaborations, and joint ventures to gain a strong foothold in the market. The major companies dominating the Alzheimer’s Disease Therapeutics and Diagnostics market in this region are Abbvie Inc., Pfizer Inc., AC Immune SA, Eisai Co Ltd., Allergan PLC, Novartis AG, Amarantus Bioscience Holdings, H. Lundbeck A/S, Anavex LifeSciences, Avid Radiopharmaceuticals, Forest Laboratories Inc., Axon Neuroscience, Daiichi Sankyo Co, TauRx Therapeutics Ltd, Eli Lilly, F. Hoffmann La Roche AG, Johnson & Johnson, GE Healthcare, Janssen Pharmaceuticals etc.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/middle-east-and-africa-alzheimers-disease-therapeutics-and-diagnostics-market-2252/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results